Published in Hepatitis Weekly, October 30th, 1995
While prednisolone, usually combined with azathioprine, is effective in maintaining remission in the majority of autoimmune hepatitis patients, most such patients experience relapse when treatment stops and need long-term therapy, noted Philip J. Johnson, M.D., and colleagues, King's College Hospital and School of Medicine and Dentistry, London, United Kingdom. However, extended corticosteroid therapy can have toxic effects.
In 1984 Johnson et al. conducted a controlled trial to study the effectiveness of maintenance therapy with azathioprine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1995-10-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.